Skip to content

Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm

Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm in At-risk Population (DAAP-PR Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05360108
Acronym
DAAP-PR
Enrollment
507
Registered
2022-05-04
Start date
2020-06-01
Completion date
2029-06-30
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Abdominal, Popliteal Artery Aneurysm

Keywords

Abdominal aortic aneurysm, Popliteal aneurysm, Screening

Brief summary

Observational, prospective, cohort study to evaluate, by an opportunistic screening program based on vascular ultrasound, the prevalence and characteristics of Abdominal Aortic Aneurysm (AAA) and Popliteal Artery Aneurysm (PAA) in a female population as well as the prevalence and characteristics of PAA in male population.

Detailed description

Abdominal aortic aneurysm (AAA) remains a highly topical issue given the potentially dramatic consequences associated with its rupture. In men, the prevalence of AAA is declining, probably due to improved management of risk factors. However, the most recent studies and international recommendations have reaffirmed that screening for AAA in men is still important and cost-effective. In contrast, data regarding the risk and characteristics of AAA in women are very limited and outdated. For this reason, the recommendations are contrasting and not univocal. About 35% of patients with AAA have a second aneurysm more distally. Popliteal artery aneurysm (PAA) is the most common. Like AAA, PAA is often asymptomatic and its main complication is thrombotic occlusion resulting in acute/chronic ischemia of the affected limb and a high prevalence of permanent sequelae (mainly amputation). Data on epidemiology and risk factors of PAA are very limited in men and absent in women. In addition, the benefit of PAA screening has never been assessed so far. The aim of this study is to evaluate, by an opportunistic screening program based on vascular ultrasound, the prevalence and characteristics of AAA and PAA in a female population as well as the prevalence and characteristics of PAA in male population. The project represents the first screening program for popliteal aneurysm. Finally, the results will allow us to better assess need for and modalities of a screening program.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Women aged ≥65 years who are current smokers * Men aged ≥65 years * Women or Men aged ≥55 years with family history (first-degree relatives) for Abdominal Aortic Aneurysm (AAA) or popliteal artery aneurysm (PAA)

Exclusion criteria

* Patient with known diagnosis of AAA or PAA * Patient already operated for AAA or PAA * AAA/PAA screening or arterial assessment of lower limbs within the last 12 months * Inability to understand and/or sign study consent * Inability to access follow-up controls

Design outcomes

Primary

MeasureTime frameDescription
Abdominal aortic measurement1 dayUltrasound of infrarenal aorta with diameter measured in mm
Popliteal artery measurement1 dayUltrasound of popliteal artery with diameter measured in mm

Secondary

MeasureTime frameDescription
Smoking habits1 dayDefined by active smoking, former smoking, never smoking
Other cardiovascular risk factors1 dayArterial hypertension, Diabetes, Dyslipidemia, Obesity
History of cardiovascular diseases1 dayCoronary artery disease, cerebrovascular disease, lower extremity peripheral artery disease, venous thromboembolism
Family history for aneurysmal disease1 dayFirst-degree relatives with aneurysmal disease
Time-consuming1 dayTime needed to perform screening
Surgical intervention for aneurysm36 monthsNumber of aneurysm operated during follow-up

Countries

Italy, Switzerland

Contacts

STUDY_CHAIRLucia Mazzolai, MD, PhD

Centre Hospitalier Universitaire Vaudois

PRINCIPAL_INVESTIGATORAdriano Alatri, MD

Centre Hospitalier Universitaire Vaudois

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026